Abstract:Magnesium (Mg) plays a key role in neurological functioning and manifestations. However, the evidence from randomized controlled trials (RCTs) and cohorts on Mg and cognitive health among adults has not been systematically reviewed. We aimed to examine the associations of various Mg forms (supplements, dietary intake, and biomarkers) with cognitive outcomes by summarizing evidence from RCTs and cohorts. PubMed, Embase, PsycINFO, and the Cochrane Central Register of Controlled Trials were searched for relevant peer-reviewed articles published up to May 3, 2024. Three random-effects models were performed, when appropriate, to evaluate the relationship between Mg and cognitive outcomes: 1) linear meta-regression, 2) nonlinear (quadratic) meta-regression, and 3) meta-analysis using Mg variables categorized based on pre-existing recommendations. Three RCTs and 12 cohort studies were included in this systematic review. Evidence from the limited number of RCTs was insufficient to draw conclusions on the effects of Mg supplements. Cohort studies showed inconsistent dose-response relationships between dietary Mg and cognitive disorders, with high heterogeneity across populations. However, consistent U-shape associations of serum Mg with all-cause dementia and cognitive impairment were found in cohorts, suggesting an optimal serum Mg concentration of ∼0.85 mmol/L. This nonlinear association was detected in meta-regression (Pquadratic = 0.003) and in meta-analysis based on the reference interval of serum Mg (0.75-0.95 mmol/L) [<0.75 compared with 0.85 mmol/L: pooled hazard ratio (HR) = 1.43; 95% confidence interval (CI) = 1.05, 1.93; >0.95 compared with 0.85 mmol/L: pooled HR = 1.30; 95% CI = 1.03, 1.64]. More evidence from RCTs and cohorts is warranted. Future cohort studies should evaluate various Mg biomarkers and collect repeated measurements of Mg intake over time, considering different sources (diet or supplements) and factors affecting absorption (for example, calcium-to-Mg intake ratio). This systematic review was preregistered in PROSPERO (CRD42023423663).

Magnesium Ions and Dementia

Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis

Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis

Neuroprotective effects of magnesium: implications for neuroinflammation and cognitive decline

Magnesium modulates amyloid-beta protein precursor trafficking and processing.

Magnesium: Pathophysiological mechanisms and potential therapeutic roles in intracerebral hemorrhage

Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation

Relations of Magnesium Intake to Cognitive Impairment and Dementia among Participants in the Women’s Health Initiative Memory Study: a Prospective Cohort Study

Dietary Calcium and Magnesium Intake and Risk for Incident Dementia: the Shanghai Aging Study

Magnesium and the Hallmarks of Aging

Prevention of Cognitive Deficits in Alzheimer’s Mouse Model by Elevating Brain Magnesium

Cross-sectional and longitudinal associations of magnesium intake and cognition in the Healthy Aging Longitudinal Study in Taiwan

Elevation of Brain Magnesium Prevents and Reverses Cognitive Deficits and Synaptic Loss in Alzheimer's Disease Mouse Model (Retraction of vol 33, pg 8423, 2013)

Adequate dietary magnesium intake may protect females but not males older than 55 years from cognitive impairment

Enhancement of learning and memory by elevating brain magnesium.

Magnesium-L-threonate treats Alzheimer's disease by modulating the microbiota-gut-brain axis

By suppressing the expression of anterior pharynx-defective-1α and -1β and inhibiting the aggregation of β-amyloid protein, magnesium ions inhibit the cognitive decline of amyloid precursor protein/presenilin 1 transgenic mice

Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis

Magnesium Regulates Endothelial Barrier Functions Through TRPM7, MagT1, and S1P1.